Nov 13, 2025
Hot Takes from IDWeek: CDC, COVID, and Two Doses of Dalbavancin
Commentary from IDWeek discussing CDC topics, COVID, and dalbavancin dosing.
Read More
Nov 10, 2025
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study
A population-based cohort study showed that early use of nirmatrelvir-ritonavir significantly improved long-term post-COVID outcomes.
Read More
Nov 4, 2025
Trial data show ensitrelvir has potent antiviral activity against COVID-19
Data from a phase 2 randomized controlled clinical trial show ensitrelvir accelerated viral clearance in patients with early symptomatic COVID-19.
Read More
